The annual revision of the EMDN ensures that MD nomenclature incorporates the latest innovations, ensuring accurate classification. These updates ensure greater compliance with regulatory requirements, thus enhancing patient safety and market transparency.
The MDCG published guidance related to this annual update:
- MDCG 2025-3: EMDN Version History
- MDCG 2025-2: Summary of EMDN 2024 Submissions and outcome of annual revision
- MDCG 2025-1: EMDN Ad hoc procedure
- MDCG 2024-2 Rev.1: Procedures for the updates of the EMDN
- MDCG 2021-12 Rev.1: FAQ on the European Medical Device Nomenclature (EMDN)
share
Events
Find an answer to the challenges you are facing in one of our upcoming events: trainings, webinars, forums...